Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.68 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.68 |
| ▸ | QPCT | Q16769 | 1/20 | 0.68 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.68 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.68 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28148737 | 0.89 | CYP11B1 (0.60) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| SCHEMBL28148752 | 0.83 | CYP11B1 (0.54) | CYP11B1CYP19A1CYP11B2CYP2A6CYP2B6 | |
| SCHEMBL21500640 | 0.83 | CYP11B1 (0.55) | CYP11B1CYP19A1CYP11B2TBXAS1CYP2A6 | |
| SCHEMBL28377018 | 0.83 | CYP19A1 (0.61) | CYP11B1CYP19A1CYP11B2CYP2A6CYP2B6 | |
| SCHEMBL22399266 | 0.82 | CYP11B1 (0.51) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| SCHEMBL21500662 | 0.82 | NAMPT (0.49) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| SCHEMBL22063900 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| Benzylimidazole SCHEMBL414 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| SCHEMBL28149990 | 0.82 | POLB (0.54) | CYP11B1CYP19A1CYP11B2CYP1A2POLB | |
| SCHEMBL164101 | 0.81 | CYP11B1 (0.47) | CYP11B1CYP19A1CYP11B2CYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103384668-B | compounds and compositions for inhibition of NAMPT | 福马TM有限责任公司 | 2017-05-31 | — | — | CN | claimed |
| CN-103384668-A | Novel compounds and compositions for inhibiting NAMPT | FORMA THERAPEUTICS INC | 2013-11-06 | — | — | CN | claimed |
| US-11547701-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-10272072-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2019-04-30 | — | — | US | disclosed |
| US-20170368039-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA TM, LLC (US) | 2017-12-28 | — | — | US | disclosed |
| CN-103384668-B | compounds and compositions for inhibition of NAMPT | 福马TM有限责任公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-103384668-A | Novel compounds and compositions for inhibiting NAMPT | FORMA THERAPEUTICS INC | 2013-11-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170368039-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | CYP11B1 703/4885CYP19A1 2052/4885CYP11B2 611/4885 |
| US-11547701-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNMT, NQO1 | CYP11B1 455/4885CYP19A1 905/4885CYP11B2 427/4885 |
| US-10272072-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNMT, NQO1 | CYP11B1 455/4885CYP19A1 905/4885CYP11B2 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.